The Altitude Inflammatory Bowel Disease Study

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2016

Conditions
Inflammatory Bowel Disease
Interventions
OTHER

hypobaric pressure chamber

hypobaric chamber: ascent within 10 minutes, 3 hour exposure to hypoxic conditions simulating an altitude of 4,000 m.a.s.l., afterwards controlled descent under continuous pulsoximetric control

OTHER

Sigmoidoscopy

To retrieve biopsies from the colon during the course of the study 3 sigmoidoscopies were performed. The first sigmoidoscopy was performed 1 day before the stay in the hypobaric chamber. The second sigmoidoscopy was performed directly after the hypobaric chamber and the third sigmoidoscopy was performed 1 week after the hypobaric chamber. During each sigmoidoscopy 6 biopsies were taken with standard size forceps (2.4 mm). One biopsy was analysed by real-time quantitative polymerase chain reaction (PCR), one biopsy was analysed by Western blotting and another biopsy was analysed for gene gene-expression by in situ hybridisation. Two biopsies were analysed by immunohistochemistry (IHC) and one biopsy was stained with hematoxylin and eosin (H\&E).

Sponsors
All Listed Sponsors
collaborator

Triemli Hospital

OTHER

collaborator

Zurich Center for Integrative Human Physiology

OTHER

collaborator

Institute of Biostatistics

UNKNOWN

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Institute of Physiology Irchel

UNKNOWN

collaborator

Institute of Veterinary Physiology

UNKNOWN

collaborator

Swiss Aeromedical Center Switzerland

UNKNOWN

collaborator

Institute of Experimental Immunology

UNKNOWN

collaborator

University Hospital, Zürich

OTHER

lead

University of Zurich

OTHER